Creatine After a Bad Night's Sleep: Does It Help?

You slept four hours, you have a full day ahead, and somewhere on your feed a headline is promising that creatine can undo the damage. I’ve read the papers behind that headline, and the honest version is more interesting than the hype and a lot more specific.

Here’s the short answer. In a handful of small, well controlled trials, creatine reduced some of the cognitive decline that comes with staying awake through the night. The most talked about study used a single dose of roughly 25 grams, given in a lab, to fifteen people who were kept awake for 21 hours. The follow up used about 14 grams and found smaller effects that mostly did not clear the study’s own statistical bar. Nothing in this literature shows that the 3 to 5 gram scoop most people take in the morning does anything for a night of bad sleep. If you want to know whether creatine after a bad night’s sleep is worth it, the answer depends entirely on which dose and which situation you mean, and this article walks through both.

What the Evidence Actually Shows

Strip away the coverage and there are five randomized, placebo controlled trials that look at creatine during sleep loss in healthy people. That number isn’t mine. It comes from a 2026 systematic review presented at the SLEEP meeting, which searched three databases, screened 169 papers, and found that only five trials met basic inclusion criteria for randomized design, a cognitive outcome, and actual sleep loss. Across those five, participants went without sleep for anywhere from 3 to 35 hours, and they received either a single weight adjusted dose or a seven day loading protocol. Every one of them reported modest improvements. Not dramatic. Modest.

Two of those five come from the same German group at Forschungszentrum Jülich and are the reason this topic exists on the internet. Two more are British studies from the mid 2000s using a week of high dose loading. The fifth is a rugby study that measured passing accuracy rather than cognition. Total participants across all five is under a hundred.

So the evidence is real, it points in one direction, and it is thin. Those three things are all true at once, and any article that only tells you the first two is selling something.

The Study Everyone Is Quoting

In February 2024 the Jülich group published a trial in Scientific Reports that has now been accessed over a million times. Fifteen healthy adults, eight of them women, average age 23, came into a lab on two separate nights. On one night they swallowed 0.35 grams of creatine monohydrate per kilogram of body weight. On the other night they got corn starch. Neither they nor the researchers knew which was which, and the order was randomized. Then they stayed awake until roughly 4 a.m., with cognitive testing and brain scans at baseline and again at three points through the night.

For a person weighing 70 kilograms, 0.35 grams per kilogram is about 25 grams of creatine in one sitting. For someone weighing 90 kilograms it’s over 31 grams. That’s five to six times a normal daily dose, taken all at once, and the authors chose it deliberately because they were testing a hypothesis: that the brain normally takes up very little creatine from the blood, but a combination of high blood levels and the metabolic stress of sleep deprivation might temporarily change that.

The results, pooled across all three nighttime test points, were that participants on creatine scored about 10 percent better on a word pair memory test than on placebo, and were substantially faster on language, logic, and arithmetic tasks, with processing time improvements of 16 to 29 percent depending on the task. Their self rated fatigue was about 8 percent lower. Brain spectroscopy, a scanning method that measures chemical concentrations in living tissue, showed that creatine prevented the drop in phosphocreatine to phosphate ratio and the slight acidification that sleep deprivation normally produces. Effects were visible at the first test, three and a half hours after the dose, and were still present at the last one, about nine hours after.

That’s a clean, well designed crossover trial with a mechanism and a behavioral effect pointing the same way. It deserves the attention it got. Three things about it get lost in translation, though.

First, fifteen people. The authors themselves flag the sample size and note that false negatives are a real possibility, which cuts both ways. Small crossover trials can produce real effects, but they also produce inflated ones, and a 29 percent speed improvement in language tasks is the kind of number that tends to shrink on replication.

Second, participants weren’t allowed to do anything. No laptops, no movies, no games, no caffeine for 48 hours before. They sat in a dim room and were spoken to if they looked like nodding off. That’s good science, because it isolates the effect of creatine, and it also means the size of the effect in real life is unknown.

Third, and this is the one that matters most for the reader searching this title: the study was designed to answer whether a massive single dose could work acutely. It says nothing about the daily dose, and the authors are clear that prior work only found brain creatine changes after weeks of supplementation.

The 2026 Follow Up and What It Didn’t Find

The same group ran the obvious next experiment. If 0.35 grams per kilogram works, what about a smaller dose? In April 2026 they published a second trial in Nutrients using 0.2 grams of creatine per kilogram in 29 people, which worked out to an average of 14.1 grams per person. Same design, same 21 hour protocol, same tests, but this time no brain scans.

The headline result was that creatine still mitigated some of the decline. Pooled across the night, participants scored about 6 percent better on logic tasks and about 6 percent better on arithmetic compared with placebo, processed language tasks roughly 12 percent faster, and showed less variable reaction times on a vigilance test. Women showed larger effects than men, especially on logic and reaction time.

Here’s what the study also found, stated plainly in the paper. The word pair memory test that improved at the high dose did not improve at the lower dose. Memory scores fell by about 15 percent from baseline under both creatine and placebo. Digit span didn’t differ. The N back working memory task didn’t differ. And of the creatine versus placebo comparisons that did reach conventional significance, only the logic score cleared the study’s own Bonferroni corrected threshold, which was set at p below 0.0063 to account for multiple comparisons. The arithmetic result came in at p equals 0.04, language speed at 0.04, and reaction time variability at 0.02. In the authors’ own words, the effect at this dose is weak, with a maximum improvement of 6 to 12 percent.

There’s one more detail I’d want you to know. The trial was registered retrospectively, after it had been run, because the authors initially didn’t classify a nutritional intervention in healthy volunteers as a clinical trial. That’s disclosed, and it’s not unusual in nutrition research, but it means the analysis plan wasn’t locked in advance. Prospective registration is the main safeguard against a study choosing which outcomes to emphasize after the fact, and this one didn’t have it.

None of this makes the 2026 trial worthless. It went in the same direction and the authors were candid about its limits. It also tells you something important about dose. Cut the dose by 40 percent and the memory effect disappears, the processing speed effects shrink, and most of what’s left doesn’t survive correction. The obvious extrapolation, that a 5 gram dose would do roughly a third of what 14 grams did, isn’t supported by anything. The authors themselves suggest the lower dose may be near the limit of what the brain can take up acutely.

The Older Studies and the Regulator Who Read Them Closely

Before Jülich, there was McMorris. In 2006 a team at the University of Chichester gave 19 young adults either 20 grams of creatine a day for seven days or placebo, then kept them awake for 24 hours with intermittent light exercise. At the 24 hour mark the creatine group showed less decline in a random movement generation task, in choice reaction time, in balance, and in mood, with lower fatigue and higher vigor. But verbal and spatial recall, the plain memory tasks, were unaffected. A second study from the same group in 2007 extended sleep deprivation to 36 hours with the same seven day loading, and again reported benefits on executive function tasks.

Then there’s Cook and colleagues in 2011, who gave ten elite rugby players a single dose of 50 or 100 milligrams per kilogram, roughly 4.5 to 9 grams for these large athletes, 90 minutes before a passing skill test after a night of 3 to 5 hours of sleep. Both creatine doses prevented the drop in passing accuracy that showed up with placebo. So did caffeine at 1 or 5 milligrams per kilogram. It’s ten people, one motor skill, no cognitive testing, and caffeine did the same job.

These are the studies a lot of aggregator sites cite as evidence that creatine “fights fatigue.” What those sites don’t mention is that the European Food Safety Authority read the McMorris trials in 2011 and again in 2024 and found them wanting. In its November 2024 opinion on creatine and cognitive function, the EFSA panel concluded that McMorris 2006, McMorris 2007, and the well known Rae 2003 memory study in vegetarians had methodological problems, including missing information on randomization, inadequate adjustment for baseline differences, multiple uncorrected comparisons, and insufficient detail on the statistical models. Its conclusion was that no conclusions could be drawn from those three studies for the purpose of substantiating a claim.

EFSA’s overall verdict was that a cause and effect relationship between creatine supplementation and improved cognitive function has not been established. That ruling governs what can be printed on a food label in the European Union. It does not bind products sold in the United States, where the FDA and FTC operate under a different framework, and I’d be misleading you if I presented it as a global ban on the idea. But EFSA reviewed 21 human trials plus additional literature with a level of rigor that no consumer article matches, and it’s worth knowing that the regulator with the most thorough public assessment on record wasn’t persuaded. Darren Candow, one of the most published creatine researchers alive and a coauthor on the meta analysis EFSA also declined to rely on, told NutraIngredients the decision was justified given how small the current body of research is, adding that most positive results relate to a metabolic stressor or came from inconsistent dosing.

That phrase, metabolic stressor, is the key to this topic. Sleep deprivation is exactly that. The studies that find effects are almost all stressor studies, and the studies in rested people mostly don’t.

What the Rested Brain Studies Tell You

The largest trial of creatine and cognition in rested adults was published in BMC Medicine in 2023. Sandkühler and colleagues gave 123 adults 5 grams of creatine daily for six weeks in a preregistered, double blind crossover design, aiming to replicate the famous Rae 2003 result. They found a small effect on backward digit span, with an effect size of 0.17, that bordered on significance and was not robust across statistical methods. The effect on abstract reasoning was 0.09, which is tiny. None of eight exploratory cognitive tests showed anything. Vegetarians didn’t benefit more than omnivores. Side effects were reported four times more often on creatine than on placebo, mostly minor, and enough participants guessed their condition that blinding was imperfect.

The authors’ summary was that creatine might have a small benefit in healthy rested adults and that the large effect reported by Rae in 2003 is very unlikely to be real. I agree, and this is the study to read before deciding whether creatine is a daily cognitive supplement. It’s the biggest, the best designed, and the least exciting.

The meta analyses haven’t fared better under scrutiny. A 2024 meta analysis in Frontiers in Nutrition pooling 16 trials and 492 participants reported benefits for memory, attention time, and processing speed, and it is now cited everywhere. It has since needed a corrigendum for a translation error, and EFSA found that it pooled multiple non independent test results from the same participants, which double counts people and inflates the apparent sample. A 2026 commentary in the same journal made the same point and noted that when a 2023 memory meta analysis by Prokopidis and colleagues was reanalyzed with proper methods after a letter to the editor, the overall memory effect stopped being significant except in older adults.

None of this dismisses creatine. It matters because the case for creatine after a bad night’s sleep rests on the stressor studies, and the rested brain literature doesn’t provide a strong backstop.

What the Studies Used Versus What People Actually Do

Here’s where the gap between research and practice becomes the whole story.

The trials that found acute effects during sleep loss used either a single dose of 14 to 31 grams, taken in the evening before an all night session, or 20 grams a day for a full week beforehand. The rugby study used a smaller acute dose, but it measured throwing accuracy, not thinking. No study has tested the thing people actually do, which is take 3 to 5 grams in the morning after a bad night and hope for the best. Not one.

That hasn’t stopped the advice from flowing. I’ve seen consumer articles recommend 25 to 35 grams a day for alertness after poor sleep, which takes a single experimental dose and turns it into a daily regimen the researchers never tested and never suggested. I’ve seen others recommend the standard 3 to 5 grams in the morning after a rough night, citing the same Jülich paper, which used five to eight times that amount and gave it the evening before. Both are wrong in opposite directions, and both cite the same study.

There’s a second gap. The lab protocol was total wakefulness through the night, with testing at midnight, 2 a.m., and 4 a.m. A bad night’s sleep for most people means four or five hours of broken sleep, followed by a normal day. Those are different physiological states. The mechanism the Jülich group proposes, that sleep deprivation raises the brain’s demand for creatine and temporarily opens the door to more uptake, is plausible and has some indirect support. A 2025 study in 16 young men found that 24 hours without sleep raised serum creatine by around 30 percent, which fits the idea that the body is mobilizing it. But nobody has shown that the door is open on a Tuesday morning after a short night, and the 2026 data suggests the effect is quite dose sensitive even in the full deprivation protocol.

A third gap is timing. Creatine reaches peak blood levels about two to three hours after ingestion, and the 2024 study saw its biggest effects around four hours after the dose. If there is an acute effect, it isn’t instant. That undermines the mental model of creatine as something you take when you feel foggy, the way you’d take caffeine.

Who These Findings Apply To and Who They Don’t

Every participant in the Jülich trials was between 20 and 40 years old, healthy, a non smoker, not on medication, and screened for sleep disorders. The McMorris participants were young adults. The rugby players were 20. If you’re 55, or you have a chronic sleep problem, or you’re on any medication, you are outside the population in every one of these studies, and the 2026 authors say explicitly that their findings may not generalize to older adults.

The 2026 trial’s sex difference is worth a careful look rather than a headline. Women responded more than men on several measures, and the authors offer reasonable biological explanations involving lower baseline brain creatine in some regions, hormonal effects on creatine synthesis, and the location of the creatine transporter gene on the X chromosome. That’s an interesting hypothesis. It’s also a subgroup analysis in a trial of 17 women and 12 men, and subgroup findings in small trials have a poor track record. The same paper found that vegetarians and omnivores both improved, without a clear difference, and Sandkühler found no diet effect at all in a much larger sample. Anyone telling you vegetarians or women should expect a bigger effect is ahead of the evidence.

One group these findings might apply to more directly is people who do the actual experimental thing: staying awake all night with work to do. Shift workers, residents on call, military personnel, new parents during a genuinely sleepless night. The Jülich protocol is closer to their reality than to a typical bad night. Even there, the tested dose is large, and I’ll come back to what that means.

Safety and the Dose Question

Creatine monohydrate is one of the most studied supplements in existence, and the 2017 International Society of Sports Nutrition position stand concluded that daily doses of 0.3 to 0.8 grams per kilogram for up to five years have not shown adverse health effects in healthy people, with weight gain from water retention as the only consistent side effect. Creatine monohydrate is also generally recognized as safe by the FDA for use in foods. That’s a reassuring safety record for daily use.

A single 25 to 30 gram dose is a different question. The 2024 trial reported no gastric discomfort in its 15 participants and the 2026 trial reported none in its 29, which is encouraging but is not the same as a safety study. Large single doses of creatine are well known to cause stomach upset and loose stools in some people, which is exactly why loading protocols spread 20 grams across four servings. Sandkühler’s trial found side effects four times more common on creatine than placebo at just 5 grams a day. If you’re considering a dose in the range these studies used, that’s a conversation to have with a doctor, particularly if you have any kidney concern, and I’d want a lot more than 44 total participants before treating a 30 gram bolus as routine.

One more trap. Because 0.35 grams per kilogram worked in the lab, some people start taking that amount regularly. The researchers tested a single dose on a single night, not a daily regimen, and the specific pattern of a huge dose whenever you slept badly is unstudied.

What We Still Don’t Know

We don’t know whether a normal daily dose helps after a bad night. No trial has tested it. If you already take 5 grams a day and you’ve been doing so for months, your muscle and possibly brain stores are already elevated, and whether that translates into any resilience on a short night has never been measured.

We don’t know whether the acute effect exists for partial sleep loss. Every positive study used 21 to 36 hours of continuous wakefulness. Four hours of sleep followed by a normal day is a different physiological state.

We don’t know how much of the lab effect survives real world conditions, or what it adds on top of your usual coffee, since participants were denied caffeine and stimulation of any kind.

We don’t know the shape of the dose response curve. Two points exist, at 0.2 and 0.35 grams per kilogram, from the same lab, and the authors caution against comparing them directly because the second study didn’t include brain measurements or a statistical comparison across trials.

And we don’t have an independent replication. Both acute studies come from one group. The McMorris studies are two decades old and EFSA found them hard to evaluate. Until a different lab in a different country runs a preregistered trial with a prespecified primary outcome, the acute sleep deprivation finding remains a promising result from one team.

What Would Change the Picture

I’d change my read of this evidence fast if a few things happened. A preregistered trial from an independent group, with one primary outcome fixed in advance and 50 or more participants, would either confirm the Jülich result or shrink it. A trial of habitual 5 gram daily users tested after a night of restricted rather than eliminated sleep would answer the question most people are actually asking. And a caffeine comparator would tell us whether creatine adds anything to what people already do.

Until then, here’s where I land. The claim that a large single dose of creatine can partially offset the cognitive cost of an all night session in young healthy adults has support from two small, well designed trials and two older, weaker ones. The effect at 14 grams is smaller and shakier than at 25 grams. The claim that your morning scoop will help you think after a bad night’s sleep is not supported by any study, and the claim that creatine improves cognition in rested people is small at best and was not accepted by the most thorough regulatory review to date.

If you’re a healthy adult facing a real all nighter, you now know exactly what was tested and what wasn’t. If you’re just tired on a Tuesday, the evidence for creatine after a bad night’s sleep isn’t there yet, and the studies you’d need to see haven’t been run.